RECOMBINANT PARTICLE BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION
    1.
    发明申请
    RECOMBINANT PARTICLE BASED VACCINES AGAINST HUMAN CYTOMEGALOVIRUS INFECTION 审中-公开
    基于重组颗粒的人类感染细胞因子疫苗

    公开(公告)号:US20150359879A1

    公开(公告)日:2015-12-17

    申请号:US14436943

    申请日:2013-10-30

    申请人: Redvax GmbH

    摘要: The invention relates to gene and protein assemblies in the form of virus-like particles and protein complexes for use as prophylactic or therapeutic vaccines, and diagnostic and R&D tools for human cytomegalovirus (HCMV) and other herpes viruses. The virus-like particles comprise one or more capsid proteins from a herpes virus or a retrovirus, three or more CMV surface proteins and optionally tegument proteins. The assemblies are prepared using a technology combining recombinant DNA with disposable cell culture and purification techniques.

    摘要翻译: 本发明涉及用作预防或治疗疫苗的病毒样颗粒和蛋白质复合物形式的基因和蛋白质组装,以及用于人巨细胞病毒(HCMV)和其他疱疹病毒的诊断和研发工具。 病毒样颗粒包含一种或多种来自疱疹病毒或逆转录病毒的衣壳蛋白,三种或更多种CMV表面蛋白和任选的纤维蛋白。 使用结合重组DNA与一次性细胞培养和纯化技术的技术制备组装体。